Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from RKLB

The Space Race Just Hit a Bottleneck—Who Benefits?

Blue Origin's grounding of New Glenn after an April 19 mishap tightens an already-constrained launch market, potentially benefiting RKLB, FLY, and LUNR.

MarketBeat

If There's a Domestic Manufacturing Boom, These 3 Stocks Could Win

A domestic manufacturing surge might still be on the horizon, and these three companies representing different industries could benefit.

MarketBeat

SpaceX IPO Frenzy: 3 Space Stocks That Could Benefit Most

The SpaceX IPO is coming. Discover three space stocks positioned to benefit as investor interest in the commercial space economy accelerates

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

MarketBeat Week in Review – 04/13 - 04/17

Stocks surged after Iran announced the Strait of Hormuz was open for commercial shipping; a sustained rally may create an opportunity in beaten-down stocks

MarketBeat

Rocket Lab Is Back at a Line in the Sand—Now What?

Rocket Lab has reclaimed its 50- and 20-day SMAs above the key $65 support level, with a move above $78 potentially signaling a higher-timeframe breakout.

MarketBeat

Looking to Profit From the Artemis II Mission? Buy RocketLab and AeroVironment Stocks.

Artemis II has sparked fresh investor interest in space. Rocket Lab and AeroVironment emerge as solid next-gen stocks to buy in an evolving defense and space market.

Barchart

Rocket Lab Gets Approval to Acquire Mynaric: Why This Matters

Rocket Lab has received regulatory approval to acquire Mynaric, a laser-optical communications specialist, with the deal expected to close in April.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Why EchoStar and Rocket Lab Stocks Could Be Top Buys Ahead of a SpaceX IPO

EchoStar holds SpaceX equity rights worth up to $11 billion. Rocket Lab posted record revenue of $602 million. Here's why both stocks could rally ahead of a SpaceX IPO.

Barchart

Out-of-This-World Options: 3 Larger, Diverse Spread Trades in Rocket Lab Stock

Rocket Lab is an emerging bet on the space industry, and options traders are clearly taking notice.

Barchart

Does Rocket Lab's $2 Billion Backlog Offset Dilution Concerns?

Rocket Lab’s $190 million hypersonic contract has propelled its backlog beyond $2 billion, capping a busy week that also included an equity raise announcement. Investors need to balance explosive contract growth against fresh dilution pressures.

Barchart

How Is Textron's Stock Performance Compared to Other Aerospace & Defense Stocks?

Textron has underperformed other aerospace & defense stocks over the past year, yet analysts remain somewhat optimistic about the stock’s outlook.

Barchart

Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape

Rocket Lab is stabilizing after an almost 30% pullback from record-highs, with shares holding key support and potentially forming a higher low.

MarketBeat

RKLB Delivers Record Results, But Neutron Delay Weighs on Shares

Rocket Lab (NASDAQ: RKLB) posted record revenue in 2025, expanded margins, and a $1.85 billion backlog, with strong near-term visibility.

MarketBeat

Rocket Lab Earnings Loom as Neutron Timeline Takes Center Stage

Rocket Lab (NASDAQ: RKLB) shares have pulled back nearly 30% from their highs ahead of a pivotal fourth-quarter earnings report.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Rocket Lab’s Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?

Understand why Rocket Lab pulled back from January highs, what the Neutron testing incident means, and the key levels and catalysts investors are watching.

Barchart

A Potential Sentiment Mismatch Makes Rocket Lab (RKLB) Stock Options an Enticing Proposition

While Monday’s sudden drop was unexpected, the smart money maintains a bullish posture toward RKLB stock.

MarketBeat

Analysts Remain Steadfast on Rocket Lab After Neutron Test Failure

Shares of Rocket Lab have fallen nearly 20% from recent record highs, following a Neutron test failure and uncertainty about its launch schedule.

MarketBeat

MarketBeat Week in Review – 01/19 - 01/23

Stocks rallied after a sharp sell-off as economic indicators pointed to a growing economy; next week may bring more volatility as "big tech" begins to report.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Rocket Lab Gets a Big Upgrade: Will Upside Follow?

Morgan Stanley just turned bullish on Rocket Lab, upgrading the stock to Overweight from Equalweight and raising its price target to a Street-high $105.

MarketBeat

5 Hot Small Caps Setting Up for Big Gains: Buy, Sell, or Hold?

Small caps are poised to lead in 2026, and these stocks are among the hottest. The question to be answered is where their stock price are heading in H1 2026.

MarketBeat

Rocket Lab’s Rally Isn’t Random—Big Catalysts Are Ahead

Rocket Lab is breaking out to new all-time highs, driven by record contract wins, strong sector-wide momentum, and a technically constructive setup.

MarketBeat

MarketBeat Week in Review – 12/29 - 01/02

Stocks staged a rally on the first day of trading in 2026, which aligns with the general sense that the markets will grind higher, despite valuation concerns

Barchart

As SpaceX Readies for Massive IPO, This Is the Space Stock You Should Be Buying

Amid anticipation for SpaceX’s historic IPO, Rocket Lab shines as an accessible and high-potential space stock with impressive 2025 gains, innovative advancements, and analyst backing for continued growth.

MarketBeat

Why 2026 Could Be Another Breakout Year for Rocket Lab

Rocket Lab has delivered exceptional performance, with shares up nearly 175% year to date, yet remains early in a catalyst-rich growth phase heading into 2026.

Barchart

RKLB Stock Bullish Diagonal Trade Targets a Price of $85 by January 16th

A bullish diagonal spread is an advanced option trade and generally not suitable for beginners, but it can have its place within an option portfolio.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.